Terms: = Prostate cancer AND MEN1, ENSG00000133895, 4221 AND Prognosis
3 results:
1. An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway.
Chen J; Zhao L; Peng H; Dai S; Quan Y; Wang M; Wang J; Bi Z; Zheng Y; Zhou S; Liu Y; Chen C; Na F
Cancer Gene Ther; 2021 Feb; 28(1-2):112-125. PubMed ID: 32632269
[TBL] [Abstract] [Full Text] [Related]
2. prostate cancer Incidence and Mortality in Relationship to Family History of prostate cancer; Findings From The PLCO Trial.
Abdel-Rahman O
Clin Genitourin Cancer; 2019 Aug; 17(4):e837-e844. PubMed ID: 31213414
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell genetic analysis reveals insights into clonal development of prostate cancers and indicates loss of PTEN as a marker of poor prognosis.
Heselmeyer-Haddad KM; Berroa Garcia LY; Bradley A; Hernandez L; Hu Y; Habermann JK; Dumke C; Thorns C; Perner S; Pestova E; Burke C; Chowdhury SA; Schwartz R; Schäffer AA; Paris PL; Ried T
Am J Pathol; 2014 Oct; 184(10):2671-86. PubMed ID: 25131421
[TBL] [Abstract] [Full Text] [Related]